Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a specific type of lung cancer called non-small cell lung cancer (NSCLC), confirmed through a tissue or cell sample, that cannot be removed by surgery and is classified as an advanced but locally contained stage (stage IIIA, IIIB, or IIIC)
• People whose cancer has not gotten worse after completing a combined chemotherapy and radiation treatment (called concurrent chemoradiotherapy)
• People who are due to receive an immunotherapy drug called Durvalumab for 12 months as part of their standard care following that treatment
• People whose cancer cells test positive for a protein called PDL1 at a level above 1%
• People who are 18 years of age or older at the time of joining the study
• People who are in good to very good general health, as measured by a standard scoring system (ECOG score of 0 or 1)
• People who are able to follow the study requirements and attend follow-up appointments
• People who have signed a written consent form that has been approved by an ethics review board

Who may not be able to join:

• People who are unwilling to sign the ethics board-approved consent form
• People for whom a blood draw through a vein is not possible
• People with a medical, mental, or psychological condition that, in the treating doctor's judgment, would prevent them from completing the study or understanding the study information

Important: Always verify eligibility with the trial site directly before applying.